Investing - Small-Cap Market Intelligence

Investing - Small-Cap Market Intelligence

Micro and small cap, investor relations, and financial news.

Subscribe Watch Trailer Share
Investing - Small-Cap Market Intelligence
  • Cyclo Therapeutics (CTDH)

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Developing Innovative Treatments for Alzheimer's

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Interview with iSIGN CEO Philip Sassower

    iSIGN (OTC: ISGN) is a leading provider of digital transaction management (DTM) software enabling fully digital (paperless) business processes. iSIGN’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and variou...

  • CTD Holdings (OTCQB: CTDH)

    CTD Holdings (OTCQB: CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rar...

  • SG Blocks (NASDAQ: SGBX)

    Watch our exclusive interview with SG Blocks (NASDAQ: SGBX), a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. SGBX offers a product that exceeds many standard building code requirements, and also supports de...

  • Elixinol (OTCQX: ELLXF)

    Watch our exclusive interview with Elixinol (OTCQX: ELLXF) co-founder Paul Benhaim. Elixinol is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands wit...

  • cbdMD (NYSE American: YCBD)

    Exclusive Interview with cbdMD (NYSE American: YCBD) CEO Marty Sumichrast discussing the company's rapid growth in a multi-billion-dollar market. The relative newcomer to its industry surpassed a $20M annual revenue run rate in its second quarter of fiscal year 2019 (ended March) and is well-posi...

  • Wuhan General (OTC: WUHN)

    Watch our exclusive interview with the CEOs of MJ MedTech, a subsidiary of Wuhan General (OTC: WUHN), and Biodelta, as they discuss the company's near-term rollout in South Africa and plans to expand into neighboring countries. An early entrant in a multi-billion-dollar market opportunity, WUHN i...

  • Intellicheck (NYSE American: IDN)

    Watch RedChip's exclusive interview with Intellicheck's CEO Bryan Lewis. Intellicheck (NYSE American: IDN) is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identity authentication and age verification. We make it possible for our clients to in...

  • Solar Business Generating Rapid Sales Growth for SinglePoint

    Exclusive interview with Greg Lambrecht, CEO of SinglePoint (OTCQB: SING). SinglePoint is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company acquired Direct Solar in May and generat...

  • Dr. Faz Chowdhurry, CEO of Nemaura Medical

    RedChip's exclusive interview with Dr. Faz Chowdhurry, CEO of Nemaura Medical (NASDAQ: NMRD). Nemaura is a medical technology company developing SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics better ma...

  • Wize Pharma Developing Innovative Treatments for Dry Eyes

    Wize Pharma_ Developing Innovative Treatments for Dry Eyes

  • ChineseInvestors.com (OTCQB: CIIX)

    ChineseInvestors.com (OTCQB: CIIX) - Targeting Chinese Consumers and Investors in North America

  • Green Organic

    Green Organic Dutchman Rapidly Growing Operations Globally

  • Emerald Health

    Emerald Health Growing Operations in Multi-Billion-Dollar Markets Globally

  • Genetic Technologies

    Genetic Technologies New Risk Tests for Breast and Colorectal Cancers

  • Piedmont Lithium Only Conventional US Lithium Development Project

    Piedmont Lithium: Only Conventional US Lithium Development Project

  • Cuentas Emerging Leader in Fintech Solving Large Unmet Need

    Cuentas Emerging Leader in Fintech Solving Large Unmet Need

  • Electra Meccanica Sales Growing for Innovative 1- and 2-Seat Electric Vehicles

    Electra Meccanica Sales Growing for Innovative 1- and 2-Seat Electric Vehicles

  • Polar Power Innovative Power Solutions for Critical Applications

    Polar Power Innovative Power Solutions for Critical Applications

  • Tenax Therapeutics Near-Term Phase 2 Results Expected to Drive Stock

    Tenax Therapeutics Near-Term Phase 2 Results Expected to Drive Stock

  • GSRX Industries Rapidly Growing Green Stock in a Multi-Billion Market

    GSRX Industries Rapidly Growing Green Stock in a Multi-Billion Market

  • MYnd Analytics, Inc Technology-Enabled Behavioral Heath Services

    MYnd Analytics, Inc Technology-Enabled Behavioral Heath Services

  • GSRX Industries Growing MJ Business

    GSRX Industries Inc. (OTCQB: GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid produc...